FDA cleared the FlowXL® System: FlowXL Flowmeter and compatible Flowprobes and Flowsensors from Transonic Systems, Inc. on Oct 27, 2026 under K261714, a traditional 510(k). The device falls under product code DPW, Flowmeter, Blood, Cardiovascular, regulated at 21 CFR 870.2100 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on May 26, 2026. The decision came 154 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Transonic Systems, Inc. in the last 12 months of the tracker.